Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease

BACKGROUND: The purpose of this study was to assess the five-year treatment effects of a short course of intravenous immunoglobulin (IVIG) in subjects with mild cognitive impairment (MCI) due to Alzheimer disease (AD). METHODS: Fifty subjects 50 to 84 years of age with MCI due to AD were administere...

Descripción completa

Detalles Bibliográficos
Autores principales: Kile, Shawn, Au, William, Parise, Carol, Rose, Kimberley, Donnel, Tammy, Hankins, Andrea, Au, Yvonne, Chan, Matthew, Ghassemi, Azad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349062/
https://www.ncbi.nlm.nih.gov/pubmed/34362303
http://dx.doi.org/10.1186/s12868-021-00651-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349062/
https://www.ncbi.nlm.nih.gov/pubmed/34362303
http://dx.doi.org/10.1186/s12868-021-00651-2

Ejemplares similares